학술논문

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial
Document Type
Article
Source
In: Lung Cancer. (Lung Cancer, September 2022, 171:26-33)
Subject
Language
English
ISSN
18728332
01695002